Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
800 (estimated)
Sponsor
Emory University · Other
Who this trial is looking for
This trial is looking for women over 35 years old in Nairobi who want to improve breast cancer screening. Participants will receive mobile health support to help with education and reminders about breast cancer check-ups.
Are You a Good Fit for This Trial?
You may be able to join if
I am a woman aged over 35 years old
I speak Kiswahili or English
I have never undergone mammography screening
I have previously undergone mammography screening
I have experienced breast abnormalities and have been referred for tests
I am currently undergoing or have received breast cancer treatment
You may not be able to join if
I am unwilling to consent
I am unable to consent
I am undergoing breast cancer treatment
I am aged 70 years and above
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This clinical trial develops and studies how well mobile health (m-Health) patient navigation (PN) strategies work to improve screening and the early detection of breast cancer in women accessing primary care clinics in Kenya. Although highly curable, breast cancer kills thousands of women in developing countries yearly. Mammography (MMG) is used for the early detection of breast cancer by creatin…
This clinical trial develops and studies how well mobile health (m-Health) patient navigation (PN) strategies work to improve screening and the early detection of breast cancer in women accessing primary care clinics in Kenya. Although highly curable, breast cancer kills thousands of women in developing countries yearly. Mammography (MMG) is used for the early detection of breast cancer by creating a picture of the breast using film or a computer. Despite the availability of MMG in all 47 counties in Kenya, screening remains low in eligible women. Early detection of breast cancer may also be improved through access to high quality clinical breast exams (CBE). However, primary care providers in Kenya face barriers to incorporating CBE into practice, including limited patient awareness of breast cancer screening. m-Health uses applications on mobile phones to deliver PN directly to the patients. The PN strategies in this study include digital platforms and tools to help with education, reminders, navigation, and motivation around breast cancer screening. This may improve screening and the early detection of breast cancer in women accessing primary care clinics in Kenya.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* AIM 1: All members of BREAKTHROUGH's Stakeholder Advisory Board (SAB) breast cancer working group
* AIM 1: Participants (patients and health providers) from primary health care clinics in Nairobi County
* AIM 1: Will include women (patients) aged over 35 years and speak either…
Inclusion Criteria:
* AIM 1: All members of BREAKTHROUGH's Stakeholder Advisory Board (SAB) breast cancer working group
* AIM 1: Participants (patients and health providers) from primary health care clinics in Nairobi County
* AIM 1: Will include women (patients) aged over 35 years and speak either Kiswahili or English
* AIM 1: Include women who:
* Have never undergone MMG screening
* Previously undergone MMG screening
* Experienced breast abnormalities and have been referred for or undergone diagnostic investigations
* Are currently undergoing or have received breast cancer treatment
* AIM 1: Health care providers and breast screening facility staff (i.e. primary care clinic nurses, MMG clinic staff and technicians) will also be recruited
* AIM 2: Will engage with a diverse group of local and national interagency stakeholders, Nairobi County health leadership, and health providers across different levels of the health system
* AIM 3: Women aged 35 years and older who are able to provide informed consent who are attending the outpatient clinics for primary health care
* AIM 4: Members of SAB breast cancer group, health facilities leadership (all health facility levels)
Exclusion Criteria:
* AIM 1: Those who will be unwilling to consent and those who are unable to consent will be excluded from the study
* AIM 2: Those who will be unwilling to consent and those who are unable to consent will be excluded from the study
* AIM 3: Women undergoing breast cancer treatment and women aged 70 years and above will be excluded
* AIM 4: Members of SAB breast cancer group, and health facilities leadership who will be unwilling and unable to consent will be excluded
Contacts
No contact information available.
What are you hoping to find?
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
